The global cell dissociation market is on track to achieve a valuation of USD 352.91 million in 2023, with a robust compound annual growth rate (CAGR) of 13.55% projected from 2023 to 2033. By the end of the forecast period, the market is anticipated to reach approximately USD 1,257.59 million.
The growth of the cell dissociation market is driven by the increasing demand for cell-based therapies and regenerative medicine, as well as advancements in cell dissociation technologies that improve efficiency and efficacy in laboratory settings. These innovations enable researchers and clinicians to isolate and culture cells more effectively, facilitating progress in areas such as cancer research, immunotherapy, and personalized medicine.
As the biopharmaceutical and biotechnology industries continue to expand, the cell dissociation market is expected to flourish, providing essential tools and solutions for cutting-edge research and development.
Technological Breakthroughs in Cell Dissociation Products Foster Market Growth
The rising interest in personalized medicine and regenerative medicine is set to propel the demand for cell dissociation solutions. Cell dissociation is a critical stage that involves evaluating a patient’s genetic profile to determine specific treatment options.
Cell dissociation materials are used to develop cell-based therapies and regenerative medicine solutions. As chronic and infectious diseases grow increasingly widespread, demand for cell dissociation products is likely to rise. Cell-based assays are used to diagnose and treat diseases such as cancer, Alzheimer’s disease, and diabetes.
The technological advancements in cell dissociation products are propelling the market’s revenue. With the development of reagents and kits that provide efficient cell dissociation, the usage in research and development applications may increase.
How Can Competitive Pressure Shape the Cell Dissociation Market?
To increase their market position, leading firms are using a variety of techniques, such as the introduction of novel products, partnerships, collaborations, mergers & acquisitions, and geographic growth.
- S2 Genomics introduced the Singulator 100 System in February 2020. For a wide range of genomic analyses and single-cell biology, the system automates the processing of solid tissue samples into suspensions of nuclei or single cells with high yields and from tiny samples. The device standardizes the process for separating solid tissues, making it easy for researchers to consistently create suspensions of excellent, highly viable nuclei or cells with little variation.
Key Players
- HiMedia Laboratories
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Thermo Fisher Scientific
- Sartorius AG
- S2 Genomics, Inc.
- Danaher Corp.
- STEMCELL Technologies
- BD
- Miltenyi Biotec
- PAN-Biotech
Key Segments
Cell Dissociation Industry by Product:
- Enzymatic dissociation
- Non-enzymatic dissociation
- Instruments & Accessories
Cell Dissociation Industry by Type:
- Cell dissociation for Tissue Dissociation
- Cell dissociation for Cell Detachment
Cell Dissociation Industry by End User:
- Cell dissociation for Pharmaceutical and Biotechnology Companies
- Cell dissociation for Research and Academic Institutes
Cell Dissociation Industry by Region:
- Cell dissociation in North America Market
- Cell dissociation in Latin America Market
- Cell dissociation in Europe Market
- Cell dissociation in East Asia Market
- Cell dissociation in South Asia and Pacific Market
- Cell dissociation in The Middle East and Africa (MEA) Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
